Cargando…

Newly Developed Topical Cefotaxime Sodium Hydrogels: Antibacterial Activity and In Vivo Evaluation

In an attempt to reach better treatment of skin infections, gel formulations containing Cefotaxime (CTX) were prepared. The gel was formulated using Carbopol 934 (C934), Hydroxypropyl Methylcellulose 4000 (HPMC 4000), Carboxymethylcellulose Sodium (Na CMC), Pectin (PEC), Xanthan Gum (XG), or Guar Gu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakaria, Azza S., Afifi, Samar A., Elkhodairy, Kadria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895050/ https://www.ncbi.nlm.nih.gov/pubmed/27314033 http://dx.doi.org/10.1155/2016/6525163

Ejemplares similares

A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies
por: Elkhodairy, Kadria A., et al.
Publicado: (2014)

Cefotaxime Mediated Synthesis of Gold Nanoparticles: Characterization and Antibacterial Activity
por: Al Hagbani, Turki, et al.
Publicado: (2022)

Development and validation of RP-HPLC method for estimation of Cefotaxime sodium in marketed formulations.
por: Lalitha, N, et al.
Publicado: (2009)

Formulation of Indomethacin Colon Targeted Delivery Systems Using Polysaccharides as Carriers by Applying Liquisolid Technique
por: Elkhodairy, Kadria A., et al.
Publicado: (2014)

Evaluation of hypercalciuria in patients receiving intravenous Cefotaxime
por: Kalantari, Zahra, et al.
Publicado: (2019)

CEFOTAXIME IN THE TREATMENT OF BACTERIAL MENINGITIS
por: Asmar, Basim I, et al.
Publicado: (1984)

In Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis
por: Jang, Hee-Chang, et al.
Publicado: (2014)

Fabrication of cefotaxime sodium-functionalized gold nanoclusters for the detection of copper ions in Chinese herbal medicines
por: Ye, Cunling, et al.
Publicado: (2019)

Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
por: Hartman, Stan J. F., et al.
Publicado: (2019)

Enhancing the Antibiotic Antibacterial Effect by Sub Lethal Tellurite Concentrations: Tellurite and Cefotaxime Act Synergistically in Escherichia coli
por: Molina-Quiroz, Roberto C., et al.
Publicado: (2012)

Hibifolin, a Natural Sortase A Inhibitor, Attenuates the Pathogenicity of Staphylococcus aureus and Enhances the Antibacterial Activity of Cefotaxime
por: Song, Wu, et al.
Publicado: (2022)

Identification and Characterization of Cefotaxime Resistant Bacteria in Beef Cattle
por: Mir, Raies A., et al.
Publicado: (2016)

The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC
por: Robinson, Andrew M, et al.
Publicado: (2016)

Population pharmacokinetics of cefotaxime in intensive care patients
por: Swartling, Maria, et al.
Publicado: (2021)

Fabrication and Evaluation of Water Hyacinth Cellulose-Composited Hydrogel Containing Quercetin for Topical Antibacterial Applications
por: Chaiwarit, Tanpong, et al.
Publicado: (2022)

Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products
por: Alarfaj, Nawal Ahmed, et al.
Publicado: (2021)

Nanoformulation of Biogenic Cefotaxime-Conjugated-Silver Nanoparticles for Enhanced Antibacterial Efficacy Against Multidrug-Resistant Bacteria and Anticancer Studies
por: Halawani, Eman M, et al.
Publicado: (2020)

A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer
por: Abo Aasy, Noha Khalifa, et al.
Publicado: (2019)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

Method Improving for Isolation and Characterization of Allergy-Inducing Polymer Impurities in Cefotaxime Sodium Medicines Available From Pharmaceutical Industry
por: Fu, Yanan, et al.
Publicado: (2022)

Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy
por: Mokhtar, Sarah, et al.
Publicado: (2022)

Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent
por: Liu, Xiaoya, et al.
Publicado: (2018)

Green Chemometric Determination of Cefotaxime Sodium in the Presence of Its Degradation Impurities Using Different Multivariate Data Processing Tools; GAPI and AGREE Greenness Evaluation
por: Sharaf, Yasmine Ahmed, et al.
Publicado: (2023)

Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes
por: Nasser, Tasneem A., et al.
Publicado: (2023)

Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects
por: Chen, Ning, et al.
Publicado: (2020)

Antibacterial Hydrogels
por: Li, Shuqiang, et al.
Publicado: (2018)

Clostridium difficile induced colitis occurring during cefotaxime therapy.
por: Green, S. T., et al.
Publicado: (1985)

Low Release Study of Cefotaxime by Functionalized Mesoporous Silica Nanomaterials
por: Mihaiescu, Dan Eduard, et al.
Publicado: (2022)

Development of double crosslinked sodium alginate/chitosan based hydrogels for controlled release of metronidazole and its antibacterial activity
por: Feyissa, Zerihun, et al.
Publicado: (2023)

Efficacy of Etimicin Sulfate Combined with Cefotaxime Sodium in the Treatment of Patients with Septic Shock and Effect on Serum Inflammatory Factor Levels and Immune Function
por: Pang, Songqiang, et al.
Publicado: (2021)

Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics
por: Abdelgalil, Riham M., et al.
Publicado: (2023)

In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels
por: Mekkawy, Aml I, et al.
Publicado: (2017)

Cefotaxime induced generalized bullous fixed drug eruption - A case report
por: Manikandan, R., et al.
Publicado: (2018)

Biocompatible and Antibacterial Nitric Oxide-Releasing Pluronic F-127/Chitosan Hydrogel for Topical Applications
por: Pelegrino, Milena T., et al.
Publicado: (2018)

Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis)
por: Sharma, Suresh Kumar, et al.
Publicado: (2006)

Cefotaxime-Resistant Salmonella enterica in Travelers Returning from Thailand to Finland
por: Gunell, Marianne, et al.
Publicado: (2014)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
por: Shang, Zhen-Hai, et al.
Publicado: (2022)

Colonization Dynamics of Cefotaxime Resistant Bacteria in Beef Cattle Raised Without Cephalosporin Antibiotics
por: Mir, Raies A., et al.
Publicado: (2018)

Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children
por: Hartman, Stan J. F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36ijmgftkipnset9nob5e6t6j8